Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2011 - FRMC

Feature
05/23/2011
Minneapolis—In recent years, pharmaceutical companies have developed numerous expensive oncology drugs to stabilize patients with cancer, a trend expected to continue throughout this decade. Although the majority of products are covered under...
Minneapolis—In recent years, pharmaceutical companies have developed numerous expensive oncology drugs to stabilize patients with cancer, a trend expected to continue throughout this decade. Although the majority of products are covered under...
Minneapolis—In recent years,...
05/23/2011
First Report Managed Care
Feature
05/23/2011
Minneapolis—Patient adherence to prescribed medications has been well documented as an important issue in containing overall costs. Researchers recently conducted a survey of adherent and nonadherent patients to aid in understanding the...
Minneapolis—Patient adherence to prescribed medications has been well documented as an important issue in containing overall costs. Researchers recently conducted a survey of adherent and nonadherent patients to aid in understanding the...
Minneapolis—Patient adherence to...
05/23/2011
First Report Managed Care
Feature
05/23/2011
Since President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, several provisions of the legislation have been enacted. However, healthcare reform remains a divisive political issue, consumer...
Since President Barack Obama signed the Patient Protection and Affordable Care Act (ACA) into law in March 2010, several provisions of the legislation have been enacted. However, healthcare reform remains a divisive political issue, consumer...
Since President Barack Obama...
05/23/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement